Last reviewed · How we verify

NCT04942392

Digital Dance for People With Parkinson's Disease During the COVID-19 Pandemic

Completed NA Last updated 28 June 2021
What this trial tests

NA trial testing Digital dance for PD in Parkinson Disease in 33 participants. Completed in 3 December 2020.

Timeline
4 September 2020
Primary endpoint
3 December 2020
3 December 2020

Quick facts

Lead sponsorUmeå University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposesupportive care
Enrollment33
Start date4 September 2020
Primary completion3 December 2020
Estimated completion3 December 2020
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Umeå University

Who can join

Eligibility, any sex, with Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Dance as a treatment to support physical, cognitive and emotional functioning, has gained increased acceptance as a healthcare intervention for people with Parkinson's Disease (PD). The impact of the COVID-19 pandemic has been far reaching with devastating effects for at-risk populations. To find alternative and safe treatment delivery options during the pandemic has been of outmost importance. This mixed-methods, feasibility study on digital for people with Parkinson's Disease aimed to investigate: (1) the feasibility and safety of a digital home-based dance intervention for people with PD; (2) change in self-reported quality of life, cognitive complaints, psychological health and fatigue; and (3) the experience of digital dance for people with PD. Twenty-three participants partook in 10 weekly digital dance classes at home via zoom. Feasibility outcomes measures were administered at post-test. Pre-post changes in self-reported quality of life, cognitive complaints, psychological health and fatigue were measured, as well as the experience of digital dance via focus groups.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Parkinson's Disease and SARS-CoV-2 Infection: Particularities of Molecular and Cellular Mechanisms Regarding Pathogenesis and Treatment.
    Anghelescu A, Onose G, Popescu C, Băilă M, et al · · 2022 · cited 14× · PMID 35625737 · DOI 10.3390/biomedicines10051000
  2. Digital Dance for People With Parkinson's Disease During the COVID-19 Pandemic: A Feasibility Study.
    Walton L, Domellöf ME, Åström ÅN, Elowson Å, et al · · 2021 · cited 14× · PMID 35185746 · DOI 10.3389/fneur.2021.743432

Verify or expand the search:

Other recruiting trials for Parkinson Disease

Currently open trials in the same condition.

Other Umeå University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04942392.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing